University of Michigan Comprehensive Cancer Center nurse practitioner G. Lita Smith has been selected to receive the 2012 American Cancer Society Lane W. Adams Quality of Life Award, a prestigious national prize for cancer caregiving.
Surgeons are not always including radiation oncologists early enough in a patient's treatment decision-making process, leaving some patients uninformed of all of their treatment options and potentially leading to more mastectomies over breast-conserving therapy, according to a new study.
Kidney cancer patients who had only their tumor removed had better survival than patients who had their entire kidney removed, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
When women at high risk of breast cancer viewed a customized web-based decision guide about prevention options, they were more likely to make a choice about prevention and to feel comfortable with their choice, a new study finds.
A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.
Scientists from the University of Michigan Comprehensive Cancer Center may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, a new study reports.
A U-M Cancer Center researcher will be the principal investigator on a new $10 million grant from Stand Up to Cancer and the Prostate Cancer Foundation that will study personalized treatments for advanced prostate cancer.
Colorectal cancer is the second biggest cancer killer, trailing only lung cancer in the number of deaths each year. In time for Colorectal Cancer Awareness Month, University of Michigan Comprehensive Cancer Center experts outline genetic counseling, screening and treatment strategies for colorectal cancer.
Two new studies provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.
Lilly Oncology On Canvas, an art exhibition honoring the journeys people face when confronted by a cancer diagnosis, will be on display at the University of Michigan Comprehensive Cancer Center from March 5-23.
A new service at the University of Michigan Comprehensive Cancer Center drastically cuts the number of additional trips to the operating room after initial breast cancer surgery by having pathologists on-site in the operating suite to assess tumors and lymph nodes immediately after they are removed.
University of Michigan pediatric oncology researcher Elizabeth R. Lawlor, M.D., Ph.D., has received a $150,000, two-year grant from CureSearch for Children's Cancer to help study metabolic changes in Ewing sarcoma with the goal of developing and testing new treatments for this bone cancer.
The U-M Women's basketball team will join the WBCA's "Play 4Kay" initiative by holding its fourth annual pink game on Feb. 5 when they host the Spartans at 3 p.m. at Crisler Center. The Wolverines are looking to raise $5,000 to benefit the University of Michigan Women's Health Program.
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study. The finding suggests a possible target for developing new ways to treat this deadly disease.
Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs don't lead to longer survival, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a common and deadly side effect of lifesaving bone marrow transplants.
Researchers at the University of Michigan Health System have found a new indicator that may predict which patients with a common type of throat cancer are most likely have the cancer spread to other parts of their bodies.
In commemoration of Cervical Cancer Month, the U-M Health System and Verizon are partnering to offer free Pap tests from 1 - 4 p.m., Sat. Jan. 21, 2012 at the Livonia Health Center, 20321 Farmington Rd., Livonia.
After Tuesday's water line break which affected the U-M Cancer Center, University Hospital, and the Medical Science 1 buildings, scheduled patient care for Wednesday has been accommodated through rescheduled appointments or relocated treatment elsewhere in the Health System.
After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease.
Reporters, producers and editors, here is our holiday gift to you: Story ideas that relate to the holidays, and some evergreen ideas that can help you fill the newspaper or broadcast during the slow news month ahead.
A technique that lets researchers monitor single cancer cells in real time as they float in liquid could help doctors study the breakaway tumor cells that cause metastasis. Metastasis is the process of the disease spreading through the body.